Switzerland

On December 15, 2025, Swixx BioPharma AG announced the signing of an agreement for a strategic investment by SK Capital Partners. The investment values Swixx BioPharma at more than EUR 1.5 bn. Swixx BioPharma is a leading global full-service partner in the distribution of biopharmaceutical products operating across multiple countries in Central and Eastern Europe, Greece, Eurasia and several CIS countries, the Middle East and Latin America. Closing is expected in the second quarter of 2026, subject to customary regulatory approvals. After closing, SK Capital will become Swixx’s lead investor. Biocorp, together with the founders and other shareholders, including Mérieux Equity Partners and HBM Healthcare Investments, will reinvest alongside SK Capital. Homburger is acting as counsel to Biocorp, the founders of Laboratorios Biopas, which was acquired by Swixx BioPharma in summer 2024 and, as part of that transaction, became shareholders in Swixx BioPharma. The Homburger team includes Andreas Müller, Claude Lambert, Hans Glent Abildgaard (all Corporate / M&A) and other subject matter specialists.  

On December 12, 2025, Aris Mining Corporation (TSX: ARIS; NYSEA: ARMN) announced the completion of its acquisition of the remaining 49% interest in the Soto Norte joint venture in Colombia from MDC Industry Holding Company LLC (Mubadala). Aris Mining Corporation now owns 100% of the Soto Norte project, a high-grade, long-life underground gold project that incorporates industry-leading environmental and social design features. The Homburger team was led by Daniel Hasler (Corporate / M&A) and included Marco Rostetter (Corporate / M&A) as well as Jürg Frick (Financing).

Zurich, 15 December 2025 Bär & Karrer is pleased to announce the election of Abdul Carrupt, Predrag Sunaric and Stephanie Walter as partners, effective 1 January 2026. Predrag Sunaric specialises in domestic and cross-border litigation as well as arbitration. He advises Swiss and international clients, including individuals and corporations, on complex commercial disputes in sectors such as real estate, insurance, pharmaceuticals, employment, corporate law, and private wealth matters. As both counsel and arbitrator, he is active in both court proceedings and arbitration cases. Stephanie Walter advises and represents Swiss and international banks, insurance companies, asset managers, and other financial institutions in a broad range of regulatory and compliance matters. Her practice includes the licensing of new financial institutions (including FinTech firms) as well as advising on mergers and acquisitions in the financial sector. She frequently acts in internal corporate and regulatory investigations and in enforcement proceedings in Switzerland and abroad. Drawing on her practical experience in the financial services industry, Stephanie brings a strong market- and client-oriented perspective to her work. Abdul Carrupt specialises in white-collar crime, financial litigation, internal investigations, asset recovery, crisis management, and sports arbitration. He advises Swiss and international clients in complex cross-border criminal proceedings, especially in matters of money laundering, anti-bribery, and corruption and leads internal investigations and governance-related crisis work. He also supports clients with cybercrime and digital finance litigation. Senior Partner Susanne Schreiber stated: "We are pleased to announce Predrag, Stephanie, and Abdul's promotion to partners. Their advancement demonstrates our ongoing dedication to developing and retaining talented professionals as our firm continues to grow." For further information please contact: Media Relations, Eric Stupp Tel: +41 58 261 50 00 Email: [email protected]

The US private equity investor SK Capital LP has acquired the Swixx BioPharma Group. The Swixx BioPharma Group is a leading global full-service partner in the distribution of biopharmaceutical products, particularly in Central and Eastern Europe and Latin America. Bär & Karrer is acting as counsel to SK Capital LP in this transaction. The team is led by Christoph Neeracher and Philippe Seiler and also includes Therry Lehmann, Thomas Rohde, Romina Lauper, Rahel Brüschweiler, Markus Mezger, Max Winnenburg (all M&A), Susanne Schreiber, Martin Leu, and Leotrim Berisha (Tax), Markus Wang and Christine Schweikard (IP/IT), Mani Reinert, Li Wei Dutler, and Martin Werner (Competition), Christian Kunz and Katharina Cardon (Data Protection), Markus Schott, Julia Stempfel, and Jan Grossniklaus (Regulatory), Rocco Rigozzi and Patrick Neher (Real Estate), Laura Widmer and Manuel Schmid (Employment), Ralph Malacrida and Colin Giezendanner (Financing), and Mariel Hoch (Public M&A). For further information please contact: Media Relations, Eric Stupp Tel: +41 58 261 50 00 Email: [email protected]